Manufacturers/Baxter Healthcare Corporation

Baxter Healthcare Corporation

35 drugs in NADAC|35 Generic,0 Brand

View Recalls (36)

Total Drugs

35

35G / 0B

Avg Price / Unit

$8.3495

$0.00 – $227.72

Avg 7d Change

+3.08%

Across 12 drugs with changes

7d Activity

10223 flat

of 35 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Drug Portfolio

35 drugs total, 35 shown

Drug Price 7d Change
CYCLOPHOSPHAMIDE 500 MG VIAL
cyclophosphamide
$227.7200
per EA
FOSAPREPITANT 150 MG VIAL
Fosaprepitant Dimeglumine
$38.5080
per EA
NALOXONE 2 MG/2 ML SYRINGE
naloxone hydrochloride
$13.0369
per ML
+1.36%
NALOXONE 4 MG/10 ML VIAL
NALOXONE HYDROCHLORIDE
$4.2587
per ML
+4.14%
NALOXONE 0.4 MG/ML VIAL
naloxone hydrochloride
$4.2587
per ML
+4.14%
FLUMAZENIL 0.5 MG/5 ML VIAL
Flumazenil
$1.0656
per ML
+3.92%
KETOROLAC 30 MG/ML VIAL
ketorolac tromethamine
$0.7389
per ML
+4.85%
TOBRAMYCIN 80 MG/2 ML VIAL
Tobramycin
$0.6294
per ML
+4.97%
FUROSEMIDE 20 MG/2 ML VIAL
furosemide
$0.4049
per ML
+1.74%
ROCURONIUM 50 MG/5 ML VIAL
Rocuronium Bromide
$0.3942
per ML
TRANEXAMIC ACID 1,000 MG/10 ML
tranexamic acid
$0.3547
per ML
FUROSEMIDE 40 MG/4 ML VIAL
furosemide
$0.3500
per ML
+1.55%
LABETALOL HCL 100 MG/20 ML VL
Labetalol Hydrochloride
$0.2354
per ML
ONDANSETRON HCL 4 MG/2 ML VIAL
ONDANSETRON HYDROCHLORIDE
$0.1864
per ML
-1.45%
SODIUM CHLORIDE 0.9% SOLUTION
Sodium Chloride
$0.0198
per ML
SODIUM CHLORIDE 0.9% SOLUTION
Sodium Chloride
$0.0198
per ML
SODIUM CHLORIDE 0.9% SOLUTION
Sodium Chloride
$0.0062
per ML
SODIUM CHLORIDE 0.9% SOLUTION
Sodium Chloride
$0.0043
per ML
LACTATED RINGERS 1,000 ML
Sodium chloride, potassium chloride, sodium lactate and calcium chloride
$0.0040
per ML
+6.88%
LACTATED RINGERS INJECTION
Sodium chloride, potassium chloride, sodium lactate and calcium chloride
$0.0040
per ML
+6.88%
SODIUM CHLORIDE 0.9% IRRIG.
sodium chloride
$0.0035
per ML
ACETIC ACID 0.25% IRRIG SOLN
Acetic Acid
$0.0030
per ML
DEXTROSE 5%-WATER IV SOLN
DEXTROSE MONOHYDRATE
$0.0027
per ML
DEXTROSE 5%-WATER IV SOLN
DEXTROSE MONOHYDRATE
$0.0027
per ML
STERILE WATER FOR INJECTION
Water
$0.0021
per ML
STERILE WATER FOR INJECTION
Water
$0.0021
per ML
STERILE WATER FOR INJECTION
Water
$0.0021
per ML
SODIUM CHLORIDE 0.9% SOLUTION
Sodium Chloride
$0.0020
per ML
-1.97%
LACTATED RINGERS INJECTION
Sodium chloride, potassium chloride, sodium lactate and calcium chloride
$0.0020
per ML
SODIUM CHLORIDE 0.45% SOLN
Sodium Chloride
$0.0019
per ML
DEXTROSE 5%-0.45% NACL IV SOLN
Dextrose and Sodium Chloride
$0.0015
per ML
DEXTROSE 5%-0.45% NACL IV SOLN
Dextrose and Sodium Chloride
$0.0015
per ML
SODIUM CHLORIDE 0.9% IRRIG.
Sodium Chloride
$0.0014
per ML
SODIUM CHLORIDE 0.9% IRRIG.
sodium chloride
$0.0014
per ML
STERILE WATER FOR IRRIGATION
Water
$0.0009
per ML

FDA Recalls (36)

Recalls matched by company name. Verify current status with FDA.

D-0296-2026
Ongoing
Class II

Sterile Water for Irrigation, 250 mL, Single-Dose Plastic Bottle, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015 NDC: 0338-0004-02.

Presence of particulate matter: plastic particles from the bottle rim were observed floating into the solution

Initiated: 12/22/2025
D-0596-2025
Ongoing
Class II

Acetaminophen Injection 1000 mg/100 mL (10 mg/mL), packaged in 100 mL Viaflo container, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, Made in Ireland, NDC 36000-306-60.

Discoloration

Initiated: 8/20/2025
D-0039-2025
Ongoing
Class II

Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01

Labeling: Missing Label

Initiated: 10/30/2024
D-0649-2024
Ongoing
Class I

Heparin (Heparin Sodium in 0.9% Sodium Chloride Injection), 2,000 units per 1,000 mL (2 units/mL), 1000 mL Sterile Single Dose Container, Rx Only, Baxter USA, NDC 0338-0433-04

Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.

Initiated: 8/1/2024
D-0587-2024
Ongoing
Class II

Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose, For Intraperitoneal Administration Only, 6000 mL per bag, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA. NDC: 0941-0457-01

Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.

Initiated: 6/17/2024
D-0336-2024
Ongoing
Class II

Norepinephrine Bitartrate in 5% Dextrose Injection, 8 mg/ 250 mL (32 mcg/mL), For Intravenous Infusion Only, 250 mL vial, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015. Made in Ireland. NDC: 0338-0108-20

Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL.

Initiated: 1/23/2024
D-0146-2024
Completed
Class II

Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), 2 mL per vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Manufactured by: Baxter Pharmaceuticals India Private Ltd, Ahmedabad 382213, India. NDC 36000-012-25

Failed pH Specifications

Initiated: 11/14/2023
D-0048-2024
Terminated
Class II

Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC 0338-0067-01

CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.

Initiated: 8/24/2023
D-1103-2023
Completed
Class III

Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.

Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.

Initiated: 8/14/2023
D-1141-2023
Terminated
Class II

Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose, 5000 mL AMBU-FLEX ll Container with yellow pull ring, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA Product code L5B5193 NDC 0941-0411-07

Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

Initiated: 8/11/2023
D-1140-2023
Terminated
Class II

DIANEAL Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution 1.5% Dextrose, packaged in a) 2000 mL AMBU-FLEX II Container bag, Product Code L5B4825, NDC 0941-0409-06; b) 5000 mL AMBU-FLEX II Container bag, Product Code L5B4826, NDC 0941-0409-07; and c) 6000 mL AMBU-FLEX II Container bag, Product Code L5B9770, NDC 0941-0409-01, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.

Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

Initiated: 8/11/2023
D-0543-2023
Completed
Class II

Dianeal PD-2 Peritonial Dialysis Solution with 1.5% Dextrose, 3000 mL per Ambu-Flex II Container bag, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA. Product Code L5B5169, NDC 0941-0411-04.

Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

Initiated: 3/15/2023
D-0542-2023
Completed
Class II

Dianeal Low Calcium (2.5 mEq/L) Peritonial Dialysis Solution with 1.5% Dextrose, packaged in a) 5000 mL per Ambu-Flex II Container bag, Product Code L5B4826, NDC 0941-0409-07; and b) 6000 mL per Ambu-Flex II Container bag, Product Code L5B9770, NDC 0941-0409-01, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.

Lack of Assurance of Sterility: Potential presence of leaks originating from the Luer component.

Initiated: 3/15/2023
D-1348-2022
Terminated
Class II

Acetaminophen Injection, 10 mg/mL, 1,000 mg/100 mL, 100 mL VIAFLO container bag, Single Dose Container, For Intravenous Use Only, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA; NDC 36000-306-60

Temperature Abuse: Product distributed in refrigerated trucks with labels attached to pallets indicating "Refrigerate Upon Arrival", however product is labeled to be stored in a controlled room temperature environment.

Initiated: 8/4/2022
D-0076-2021
Terminated
Class II

Bupivacaine Hydrochloride in 8.25% Dextrose Injection, USP Spinal 0.75% (15 mg/2 mL) 10 x 2 mL single-dose ampules, Rx only, Manufactured for: Baxter Healthcare Corporation Deerfield, IL 60015 USA, Manufactured by: Baxter Pharmaceuticals India Private Ltd Ahmedabad 382213 India, NDC 36000-092-10

Presence of particulate matter in solution - black and transparent particles

Initiated: 10/7/2020
D-0517-2020
Terminated
Class II

0.9% Sodium Chloride Irrigation USP 5000 mL bags, Rx Only, Baxter Healthcare Corporation Deerfield, IL 60015, NDC 0338-0047-29

Lack of Assurance of Sterility: Product has the potential to leak.

Initiated: 11/19/2019
D-1514-2019
Terminated
Class II

0.9% Sodium Chloride Injection USP, 100 mL Viaflex Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38.

Lack of Assurance of Sterility: Bags have potential to leak.

Initiated: 7/18/2019
D-1435-2019
Terminated
Class II

Sevoflurane, USP Inhalation Anesthetic 250 mL bottles, Rx only, Manufactured for Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 10019-651-64

Failed Stability Specifications

Initiated: 6/13/2019
D-0351-2019
Terminated
Class II

Dianeal Low Calcium (2.5 mEq/L) Peritoneal Dialysis Solution with 1.5% Dextrose, 2000 mL UltraBag container bag, Rx only; Baxter Healthcare Corporation, Deerfield, IL 60015; Product Code 5B9766, NDC 0941-0424-52.

Lack of Assurance of Sterility: Confirmed customer complaints for leaks on the tubing.

Initiated: 1/2/2019
D-0222-2019
Terminated
Class III

Metoprolol Tartrate Injection, USP, 5 mg/ 5 mL (1 mg/mL), 5 mL per sterile single use glass vial, Rx Only, Manufactured for: Claris Lifesciences, Inc., North Brunswick, NJ 08902. By: Claris Injectables Ltd., Gujarat, India. NDC: 36000-033-10

Failed pH Specifications: Upward shift in the pH of the solution within the shelf life of the impacted lots.

Initiated: 10/15/2018
D-1215-2018
Terminated
Class III

Levofloxacin Injection in 5% Dextrose, 5 mg/mL, packaged in a) 50 mL (NDC 36000-046-24), b) 100 mL (NDC 36000-047-24), c) 150 mL (NDC 36000-048-24) Container bags, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India.

Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

Initiated: 9/25/2018
D-1190-2018
Terminated
Class II

0.9% Sodium Chloride Injection USP 50 mL Viaflex container Baxter Healthcare Corporation Deerfield, IL 60015 -- NDC 0338-0049-31

cGMP Deviation

Initiated: 9/6/2018
D-1128-2018
Terminated
Class II

0.9% Sodium Chloride Injection USP 100 mL bags, Rx only, Baxter Healthcare Corporation Deerfield, IL 60015 USA, NDC 0338-0049-18

CGMP Deviations

Initiated: 8/21/2018
D-1035-2018
Terminated
Class III

Levofloxacin Injection in 5% Dextrose, 500 mg (5 mg/mL), 500 mg in 100 mL 5% Dextrose, 100 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-047-24.

Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

Initiated: 8/1/2018
D-1034-2018
Terminated
Class III

Levofloxacin Injection in 5% Dextrose, 250 mg (5 mg/mL), 250 mg in 50 mL 5% Dextrose, 50 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-046-24.

Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

Initiated: 8/1/2018
D-1036-2018
Terminated
Class III

Levofloxacin Injection in 5% Dextrose, 750 mg (5 mg/mL), 750 mg in 150 mL 5% Dextrose, 150 mL Single Use Container bag, Rx only, Manufactured for: Claris Lifesciences Inc., North Brunswick, NJ 08902; By: Claris Injectables Ltd., Gujarat, India, NDC 36000-048-24.

Superpotent Drug: High out of specification results for levofloxacin resulting in increased concentration of solution.

Initiated: 8/1/2018
D-0573-2018
Terminated
Class I

Nexterone (amiodarone HCl) Premixed Injection, 150mg/100mL, 100-mL bag, Rx Only, Sterile, Baxter Healthcare Corporation, Deerfield, IL. NDC 43066-150-10

Presence of Particulate Matter:Particulate identified as polyethylene, the primary constituent of the film and ports used to manufacture the bag in which product is packaged

Initiated: 11/10/2017
D-0030-2018
Terminated
Class I

Intralipid 20%, A 20% I.V. Fat Emulsion, 100 ml bag, Rx only, Manufactured by Fresenius Kabi, Uppsala, Sweden for Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-0519-58

Temperature Abuse: A portion of this product lot was exposed to subfreezing temperatures, which is outside of the acceptable storage range listed on the product labeling, during transit to a distribution facility.

Initiated: 9/15/2017
D-0973-2017
Terminated
Class II

0.9% Sodium Chloride Injection, USP, 100 mL VIAFLEX Container, Rx Only, Baxter Healthcare Corporation, Deerfield IL 60015 USA, Product Code: 2B1309, NDC: 0338-0049-38

Lack of Assurance of Sterility: Bags have the potential to leak.

Initiated: 7/6/2017
D-0972-2017
Terminated
Class II

5% Dextrose Injection, USP, 100 mL VIAFLEX Plastic Container, Rx only, Baxter Healthcare Corporation, Deerfield IL 60015 USA, Product Code: 2B0089, NDC: 0338-0017-38

Lack of Assurance of Sterility: Bags have the potential to leak.

Initiated: 7/6/2017
D-0957-2017
Terminated
Class II

0.9% Sodium Chloride Injection USP, 250 mL VIAFLEX Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015; Distributed in Canada by Baxter Corporation, Toronto, Ontario, Canada, Product Code: 2B1322, NDC 0338-0049-02.

Lack of Assurance of Sterility: Customer complaints for leaking bags.

Initiated: 7/6/2017
D-0788-2017
Terminated
Class II

Fluconazole Injection, USP, 200 mg/100 mL (2mg/mL), 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1446, NDC 0338-6046-48

Lack of assurance of sterility: customer complaints received for the presence of leaks.

Initiated: 5/15/2017
D-0789-2017
Terminated
Class II

Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 0338-6010-48

Lack of assurance of sterility: customer complaints received for the presence of leaks.

Initiated: 5/15/2017
D-0206-2017
Terminated
Class II

Fluconazole Injection, USP, 200 mg/100 mL (2mg/mL), 100 mL Single-Dose Intravia Container bag, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product Code 2J1446, NDC 0338-6046-48.

Lack of Assurance of Sterility: confirmed customer complaints of leaking bags.

Initiated: 12/6/2016
D-0425-2017
Terminated
Class II

10% Premasol sulfite-free (Amino Acid) Injection, 2000 mL bulk package, Rx only, Baxter Healthcare Corporation, Clintec Nutrition Division, Deerfield, IL 60015 USA, NDC 0338-1130-06

Discoloration: there were customer reports of yellow discolored solution. The yellow coloration is the result of oxidation of the amino acid tryptophan due to a damaged overpouch.

Initiated: 12/6/2016
D-1816-2015
Terminated
Class II

0.9% Sodium Chloride Injection, USP, 100 mL MINI-BAG VIAFLEX Container, Single Dose Container, Rx Only, Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-0049-38

Lack of Assurance of Sterility: Recalling firm reported a complaint for mold on the interior surface of the overpouch.

Initiated: 9/2/2015